He was extremely complimentary about his co-lead, Dylan O’Brien (of Maze Runner movie fame), who plays two characters ... I came for the brightly colored aesthetics and stayed for the gory practical ...

He was extremely complimentary about his co-lead, Dylan O’Brien (of Maze Runner movie fame), who ... I came for the brightly colored aesthetics and stayed for the gory practical effects ...

O'Brien, who is known for Teen Wolf and The Maze Runner, plays a complicated and ... Shot with a unique indie aesthetic, Ponyboi captures the raw and unvarnished challenges of its intersex ...

To save their friends, they must break into the legendary Last City, a WCKD-controlled labyrinth that may turn out to be the deadliest maze of all. Anyone who makes it out alive will get answers ...

Maze Therapeutics has set out plans for a $131 million IPO as the company prepares to start dosing its lead kidney drug in a phase 2 trial. The Bay Area-based biotech unveiled its ambition earlier ...

Surely Fifty Shades of Grey had the same impact. But a funny thing about after Anastasia Steele and Christian Grey topped the ...

This time, we’re gonna win, damnit!” proclaims a grinning Wes Ball, director of last summer’s Kingdom of the Planet of the ...

Obesity biotech Metsera and renal and metabolic-focused Maze Therapeutics have met their IPO expectations as the two companies prepare to join the Nasdaq this morning. While Metsera is offering ...

Rochester Institute of Technology (RIT) transgender runner Sadie Schreiner boasted about a victory at a women’s track and field meet over the weekend. Schreiner won the 200-meter event with a ...

Maze seeks as much as $133 mln in New York IPO Backers include Alphabet's GV and Third Rock Ventures Biotech IPOs set for ramp up in coming weeks Jan 27 (Reuters) - Drug developer Maze ...